6-K

REPORT OF FOREIGN PRIVATE ISSUER

Company: Sofgen Pharma S.A.
Filed: May 1, 2024
Period of Report: May 1, 2024
Accession Number: 0001213900-24-038501

View Document ↗ View on SEC.gov ↗